Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q1 2016 call → NOWe need to analyze the transcript for the two conditions. The question asks: "On this call, is management's account of the just-reported period built substantially around REAL BUSINESS ACTIVITY THAT CROSSED FROM NOT-HAPPENING TO HAPPENING PARTWAY THROUGH THE PERIOD OR JUST AROUND ITS EDGES — and does management make clear that this newly started activity is still completing its climb, so the period's reported numbers averaged the 'before' and 'after' and therefore sit below the level at which the business is already running?" We need to answer YES if both halves are present: (1) period contained real starts narrated as starts, and (2) the climb is incomplete and printed numbers lag it. Let's examine the transcript. The company is Curis, Inc. They discuss CUDC-907, CA170, and Erivedge. The period is Q1 2016. Key points: - CUDC-907: Phase 2 trial initiated in January 2016. They completed enrollment in monotherapy arm of Phase 1. They report responses. But the Phase 2 trial is ongoing. They mention "initial costs for the Phase 2 trial that was initiated in January 2016" in R&D expenses. So the Phase 2 trial started in the period. But is that a "real business activity" that crossed from not-happening to happening? It's a clinical trial, not revenue-generating. The question is about business activity that generates revenue or output. Clinical trials are not revenue. So likely not. - CA170: They expect to enter clinic later this quarter. "Later this quarter, we expect CA170 to become the world's first orally administered checkpoint targeting immunooncology drug candidate to enter the clinic." That is a future event, not yet started. So not a start in the period. - Erivedge: Roche initiated two clinical studies. That's also clinical trials, not revenue. - The financial results: Revenues were $1.7 million for each of the first quarters of 2016 and 2015. Revenues are primarily royalty revenues from Erivedge. No new revenue-generating activity started. - They mention increased R&D spending due to Phase 2 trial initiation. But that's cost, not revenue.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.